BACKGROUND: Helicobacter pylori is the leading risk factor for gastric cancer, yet only a fraction of infected individuals ever develop neoplasia. METHODS: To identify potential predictive biomarkers, we assessed the association of 15 antibodies to H. pylori proteins and gastric cancer in a nested case-control study. Blood levels of antibodies were assessed using multiplex serology for 226 incident cases and 451 matched controls from the Shanghai Men's Health Study. ORs and 95% confidence intervals (CI) were calculated using conditional logistic regression. RESULTS: Seropositivity to four (Omp, HP0305, HyuA, and HpaA) proteins was associated with a 1.5- to 3-fold increased risk for gastric cancer. When excluding cases diagnosed within 2 years of study enrollment, seropositivity to two additional proteins (CagA and VacA) showed significant associations with risk. Compared with individuals with three or fewer seropositive results to the six virulent proteins identified in this population, individuals with four to five seropositive results were at a 2-fold increased risk (OR, 2.08; 95% CI, 1.31-3.30) and individuals seropositive to all six proteins had a 3.5-fold increase in risk (OR, 3.49; 95% CI, 2.00-6.11) for gastric cancer. Among individuals diagnosed at least 2 years after study enrollment, these associations were even stronger (ORs, 2.79 and 4.16, respectively). CONCLUSIONS: Increasing number of seropositives to six H. pylori proteins may be a risk marker for distal gastric cancer in China. IMPACT: In a population with a 90% prevalence of CagA-positive H. pylori infection, assessment of additional virulent H. pylori proteins might better identify individuals at high risk for gastric cancer.
BACKGROUND:Helicobacter pylori is the leading risk factor for gastric cancer, yet only a fraction of infected individuals ever develop neoplasia. METHODS: To identify potential predictive biomarkers, we assessed the association of 15 antibodies to H. pylori proteins and gastric cancer in a nested case-control study. Blood levels of antibodies were assessed using multiplex serology for 226 incident cases and 451 matched controls from the Shanghai Men's Health Study. ORs and 95% confidence intervals (CI) were calculated using conditional logistic regression. RESULTS: Seropositivity to four (Omp, HP0305, HyuA, and HpaA) proteins was associated with a 1.5- to 3-fold increased risk for gastric cancer. When excluding cases diagnosed within 2 years of study enrollment, seropositivity to two additional proteins (CagA and VacA) showed significant associations with risk. Compared with individuals with three or fewer seropositive results to the six virulent proteins identified in this population, individuals with four to five seropositive results were at a 2-fold increased risk (OR, 2.08; 95% CI, 1.31-3.30) and individuals seropositive to all six proteins had a 3.5-fold increase in risk (OR, 3.49; 95% CI, 2.00-6.11) for gastric cancer. Among individuals diagnosed at least 2 years after study enrollment, these associations were even stronger (ORs, 2.79 and 4.16, respectively). CONCLUSIONS: Increasing number of seropositives to six H. pylori proteins may be a risk marker for distal gastric cancer in China. IMPACT: In a population with a 90% prevalence of CagA-positive H. pylori infection, assessment of additional virulent H. pylori proteins might better identify individuals at high risk for gastric cancer.
Authors: N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper Journal: N Engl J Med Date: 2001-09-13 Impact factor: 91.245
Authors: P Correa; C Cuello; E Duque; L C Burbano; F T Garcia; O Bolanos; C Brown; W Haenszel Journal: J Natl Cancer Inst Date: 1976-11 Impact factor: 13.506
Authors: Gaby Haas; Galip Karaali; Karl Ebermayer; Wolfram G Metzger; Stephanie Lamer; Ursula Zimny-Arndt; Susanne Diescher; Ulf B Goebel; Konstanze Vogt; Artur B Roznowski; Bertram J Wiedenmann; Thomas F Meyer; Toni Aebischer; Peter R Jungblut Journal: Proteomics Date: 2002-03 Impact factor: 3.984
Authors: Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen Journal: JAMA Date: 2004-01-14 Impact factor: 56.272
Authors: Alexander Krah; Stephan Miehlke; Klaus-Peter Pleissner; Ursula Zimny-Arndt; Christian Kirsch; Norbert Lehn; Thomas F Meyer; Peter R Jungblut; Toni Aebischer Journal: Int J Cancer Date: 2004-01-20 Impact factor: 7.396
Authors: M Constanza Camargo; Mauricio Beltran; Carlos J Conde-Glez; Paul R Harris; Angelika Michel; Tim Waterboer; Astrid Carolina Flórez; Javier Torres; Catterina Ferreccio; Joshua N Sampson; Michael Pawlita; Charles S Rabkin Journal: Int J Cancer Date: 2015-07-16 Impact factor: 7.396
Authors: Gwen Murphy; Neal D Freedman; Angelika Michel; Jin-Hu Fan; Philip R Taylor; Michael Pawlita; You-Lin Qiao; Han Zhang; Kai Yu; Christian C Abnet; Sanford M Dawsey Journal: Int J Cancer Date: 2015-05-05 Impact factor: 7.396
Authors: Gwen Murphy; Angelika Michel; Philip R Taylor; Demetrius Albanes; Stephanie J Weinstein; Jarmo Virtamo; Dominick Parisi; Kirk Snyder; Julia Butt; Katherine A McGlynn; Jill Koshiol; Michael Pawlita; Gabriel Y Lai; Christian C Abnet; Sanford M Dawsey; Neal D Freedman Journal: Hepatology Date: 2014-07-30 Impact factor: 17.425
Authors: Meira Epplein; Yong-Bing Xiang; Qiuyin Cai; Richard M Peek; Honglan Li; Pelayo Correa; Jing Gao; Jie Wu; Angelika Michel; Michael Pawlita; Wei Zheng; Xiao-Ou Shu Journal: Cancer Causes Control Date: 2013-09-20 Impact factor: 2.506
Authors: Ramin Shakeri; Reza Malekzadeh; Dariush Nasrollahzadeh; Michael Pawlita; Michael Pawilta; Gwen Murphy; Farhad Islami; Masoud Sotoudeh; Angelika Michel; Arash Etemadi; Tim Waterboer; Hossein Poustchi; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Farin Kamangar; Christian C Abnet Journal: Cancer Res Date: 2015-09-17 Impact factor: 12.701
Authors: Meira Epplein; Michael Pawlita; Angelika Michel; Richard M Peek; Qiuyin Cai; William J Blot Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-09-17 Impact factor: 4.254
Authors: M Constanza Camargo; Kyoung-Mee Kim; Keitaro Matsuo; Javier Torres; Linda M Liao; Douglas R Morgan; Angelika Michel; Tim Waterboer; Jovanny Zabaleta; Ricardo L Dominguez; Yasushi Yatabe; Sung Kim; Erick R Rocha-Guevara; Jolanta Lissowska; Michael Pawlita; Charles S Rabkin Journal: Helicobacter Date: 2015-08-07 Impact factor: 5.753